The dyspnoea–inactivity vicious circle in COPD: Development and external validation of a conceptual model

European Respiratory Journal

Volumn 52, Issue 3, 2018, Pages

  Ramon, Maria A ^a,b   Riet, Gerben Ter ^c   Carsin, Anne Elie ^d,e,f,g   Gimeno Santos, Elena ^b,h,i   Agustí, Alvar ^b,h   Antó, Josep M ^d,e,f,g   Donaire Gonzalez, David ^d,e,f   Ferrer, Jaume ^a,b,j   Rodríguez, Esther ^a,b   Rodriguez Roisin, Robert ^b,h   Puhan, Milo A ^k   Garcia Aymerich, Judith ^d,e,f  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

^g HOSPITAL DEL MAR   (Spain)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^j UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^k UNIVERSITY OF ZURICH   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DYSPNEA INACTIVITY VICIOUS CIRCLE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RESPIRATORY TRACT PARAMETERS; VALIDATION STUDY; CLINICAL TRIAL; DYSPNEA; INTERNATIONAL COOPERATION; LUNG; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; THEORETICAL MODEL;

AGED; DISEASE PROGRESSION; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERNATIONALITY; LUNG; MALE; MIDDLE AGED; MODELS, THEORETICAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 85056732761     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00079-2018     Document Type: Article

References (43)

1. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 2017; 195: 557–582.
2. Miravitlles M, Anzueto A, Legnani D, et al. Patient’s perception of exacerbations of COPD – the PERCEIVE study. Respir Med 2007; 101: 453–460.
3. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 972–977.
4. Hartman JE, Boezen HM, de Greef MHG, et al. Consequences of physical inactivity in chronic obstructive pulmonary disease. Expert Rev Respir Med 2010; 4: 735–745.
5. Cooper CB. Exercise in chronic pulmonary disease: limitations and rehabilitation. Med Sci Sports Exerc 2001; 33: S643–S646.
6. Breyer M, Breyer-Kohansal R, Funk G, et al. Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res 2010; 22: 1–9.
7. Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med 2006; 119: S32–S37.
8. Polkey MI, Moxham J. Attacking the disease spiral in chronic obstructive pulmonary disease. Clin Med 2006; 6: 190–196.
9. Decramer M, Rennard S, Troosters T, et al. COPD as a lung disease with systemic consequences – clinical impact, mechanisms, and potential for early intervention. COPD 2008; 5: 235–256.
10. Earp JA, Ennett ST. Conceptual models for health education research and practice. Health Educ Res 1991; 6: 163–171.
11. Centre for Reviews and Dissemination. Systematic reviews. CRD’s guidance for undertaking reviews in health care. 2009. www.york.ac.uk/inst/crd/SysRev/!SSL!/WebHelp/SysRev3.htm Date last accessed: May 31, 2017.
12. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2. London, Cochrane, 2009.
13. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151: W65–W94.
14. Garcia-Aymerich J, Gómez FP, Benet M, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66: 430–437.
15. Strassmann A, Frei A, Haile SR, et al. Commonly used patient-reported outcomes do not improve prediction of COPD exacerbations: a multicenter 4½ year prospective cohort study. Chest 2017; 152: 1179–1187.
16. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581–586.
17. Dipietro L, Caspersen CJ, Ostfeld AM, et al. A survey for assessing physical activity among older adults. Med Sci Sports Exerc 1993; 25: 628–642.
18. Donaire-Gonzalez D, Gimeno-Santos E, Serra I, et al. Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients. Arch Bronconeumol 2011; 47: 552–560.
19. Siebeling L, Wiebers S, Beem L, et al. Validity and reproducibility of a physical activity questionnaire for older adults: questionnaire versus accelerometer for assessing physical activity. Clin Epidemiol 2012; 4: 171–180.
20. Puhan MA, Siebeling L, Zoller M, et al. Simple functional performance tests and mortality in COPD. Eur Respir J 2013; 42: 956–963.
21. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591–597.
22. Garcia-Aymerich J, Gómez FP, Antó JM. Caracterización fenotípica y evolución de la EPOC en el estudio PAC-COPD: diseño y metodología. [Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD study: design and methods.] Arch Bronconeumol 2009; 45: 4–11.
23. Siebeling L, ter Riet G, van der Wal WM, et al. ICE COLD ERIC – International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts – study protocol for an international COPD cohort study. BMC Pulm Med 2009; 9: 15.
24. MacCallum RC, Browne MW, Sugawara HM. Power analysis and determination of sample size for covariance structure modeling. Psychol Methods 1996; 1: 130–149.
25. Bollen K. Structural equation models. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. New York, Wiley, 1998; pp. 4363–4372.
26. Hooper D, Coughlan J, Mullen MR. Structural equation modelling: guidelines for determining model fit. Electron J Business Res Methods 2008; 6: 53–60.
27. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 5th Edn. New York, Allyn & Bacon, 2007.
28. Browne MW, Cudeck R. Alternative ways of assessing model fit. Sociol Methods Res 1992; 21: 123–131.
29. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Model 1999; 6: 1–55.
30. Altenburg WA, Bossenbroek L, de Greef MHG, et al. Functional and psychological variables both affect daily physical activity in COPD: a structural equations model. Respir Med 2013; 107: 1740–1747.
31. Dubow EF, Boxer P, Huesmann LR. Long-term effects of parents’ education on children’s educational and occupational success: mediation by family interactions, child aggression, and teenage aspirations. Merrill Palmer Q 2009; 55: 224–249.
32. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006; 119: 21–31.
33. Decramer M. Tiotropium as essential maintenance therapy in COPD. Eur Respir Rev 2006; 15: 51–57.
34. Donaldson AV, Maddocks M, Martolini D, et al. Muscle function in COPD: a complex interplay. Int J COPD 2012; 7: 523–535.
35. Maltais F. Exercise and COPD: therapeutic responses, disease-related outcomes, and activity-promotion strategies. Phys Sportsmed 2013; 41: 66–80.
36. Garcia-Aymerich J, Pitta F. Promoting regular physical activity in pulmonary rehabilitation. Clin Chest Med 2014; 35: 363–368.
37. Corhay JL, Dang DN, Van Cauwenberge H, et al. Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy. Int J Chron Obstruct Pulmon Dis 2014; 9: 27–39.
38. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ ERS position paper. Eur Respir J 2004; 23: 932–946.
39. O’Donnell DE, Guenette JA, Maltais F, et al. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest 2012; 141: 753–762.
40. Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1395–1399.
41. Ramon MA, Ferrer J, Gimeno-Santos E, et al. Inspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD. Respirology 2016; 21: 476–482.
42. Ramon MA, Gimeno-Santos E, Ferrer J, et al. Hospital admissions and exercise capacity decline in patients with COPD. Eur Respir J 2014; 43: 1018–1027.
43. Goldstein RS, Hill K, Brooks D, et al. Pulmonary rehabilitation. A review of the recent literature. Chest 2014; 142: 738–749.